Everest Medicines (Singapore) Pte. Ltd.
3 clinical trials · Sponsor
◉ Watch Everest Medicines (Singapore) Pte. Ltd.
| Record | Firm | Date |
|---|---|---|
| Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older (NCT05534048) | Everest Medicines (Singapore) Pte. Ltd. | 2023-02-03 |
| Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older (NCT05534035) | Everest Medicines (Singapore) Pte. Ltd. | 2023-02-03 |
| Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301 (NCT05534919) | Everest Medicines (Singapore) Pte. Ltd. | 2022-12-09 |
Track Everest Medicines (Singapore) Pte. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.